Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksONESOURCE
resources
ONESOURCE

Onesource Specialty Pharma Ltd.

NSE: ONESOURCE
BSE: 544292
Sector: Healthcare
Industry: Pharmaceuticals
1,638.80+26.8 (+1.66%)
9 Jul, 2:29 PM

Annual Reports and Financial Documents

Onesource Specialty Pharma Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
202420252026
Annual Reports—FY 2025—
Quarterly Results—
Conference Calls—
Presentations——

Corporate Announcements and Regulatory Filings

Onesource Specialty Pharma Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • General9 Jul 2026
    Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015
    We refer to the intimation made earlier today by Dr. Reddy''s Laboratories (DRL) regarding delay in commercial supplies of Semaglutide. Refer intimation attached.
  • Allotment of ESOP / ESPS8 Jul 2026
    Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
    Allotment of 24,190 equity shares of Re. 1/- under ONESOURCE ESOP 2021 on July 08, 2026.
  • General2 Jul 2026
    Completion Of US-FDA Inspection At Sterile Product Division (SPD) Facility At Bengaluru
    We wish to inform that a routine current Good Manufacturing (cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at the Sterile Product Division facility ....
  • Closure of Trading Window24 Jun 2026
    Closure of Trading Window
    Intimation of closure of Trading window for declaration of unaudited financial results for the quarter ended June 30, 2026.
  • General19 May 2026
    General- Update
    In furtherance to the intimation dated May 13, 2026, w.r.t the resignation of SMP, please find enclosed the resignation document.
  • General16 May 2026
    General-Update
    We wish to inform that the Government of Karnataka has accorded in-principle approval for the application submitted by the Company for Unit-II expansion project under the Karnataka Industrial ....
  • Newspaper Publication14 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Intimation about publication of newspaper advertisement - Extract of Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026
  • Analyst / Investor Meet13 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Audio Recording of Earnings call pertaining to the Audited Financial Results for the quarter and financial year ended March 31, 2026
  • Press Release / Media Release13 May 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Onesource announces FY 2026 results with strong Q4 performance; reaffirms FY28 guidance.
  • General13 May 2026
    Update On Composite Scheme Of Amalgamation
    Update on Composite Scheme of Arrangement and Amalgamation (Merger by Absorption) amongst Steriscience Specialities Private Limited, Brooks Steriscience Limited, Steriscience Pte. Limited, ....
  • Appointment of Statutory Auditor/s13 May 2026
    Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
    Appointment of BSR & Co.LLP Chartered Accountants as the Statutory Auditors of the Company.
  • Allotment of ESOP / ESPS13 May 2026
    Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
    Allotment of 3,150 Equity Shares of Re.1/- each under ONESOURCE ESOP SCHEME 2021.
  • Change in Management13 May 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Intimation reagrding resignation of Senior Management Personnel effective from May 13, 2026
  • Outcome of Board Meeting13 May 2026
    Board Meeting Outcome for Intimation Of The Outcome Of The Board Meeting Dated May 13, 2026 For Approval Of The Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2026
    Intimation of the outcome of the Board meeting dated May 13, 2026 for approval of the Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026
  • Analyst / Investor Meet7 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation regarding earnings call to be held on May 13, 2026
  • Board Meeting7 May 2026
    Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015
    Onesource Specialty Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve the Audited Standalone ....
  • Press Release / Media Release4 May 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    OneSource supports Second Generic Semaglutide approval in Canada- Enables commercialisation for the first two entrants in the World''s second largest Semaglutide market.
  • Press Release / Media Release29 Apr 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    OneSource''s Partner Dr. Reddy''s Laboratories receives Health Canada approval for Generic Semaglutide Injection.
  • General28 Apr 2026
    General-Update
    Intimation regarding receipt of EU GMP Certificate for Sterile Product Division
  • Press Release / Media Release21 Apr 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press release: Orbicular''s Partner secures tentative U.S. ANDA approval for a generic version of Ozempic (Semaglutide Injection), supported by OneSource as CDMO Partner.

Frequently Asked Questions

Where can I download the annual report of Onesource Specialty Pharma Ltd.?
Annual reports of Onesource Specialty Pharma Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Onesource Specialty Pharma Ltd.?
Quarterly earnings results and presentations of Onesource Specialty Pharma Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Onesource Specialty Pharma Ltd. publish earnings call transcripts?
Earnings call transcripts of Onesource Specialty Pharma Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Onesource Specialty Pharma Ltd.?
Investor presentations and annual day presentations of Onesource Specialty Pharma Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Onesource Specialty Pharma Ltd.?
Corporate announcements and regulatory filings of Onesource Specialty Pharma Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Onesource Specialty Pharma Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Onesource Specialty Pharma Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Onesource Specialty Pharma Ltd.?
The ISIN (International Securities Identification Number) of Onesource Specialty Pharma Ltd. is INE013P01021. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Onesource Specialty Pharma Ltd. listed?
Onesource Specialty Pharma Ltd. is listed on NSE and BSE. The NSE symbol is ONESOURCE and the BSE code is -.
Where can I find the shareholding pattern of Onesource Specialty Pharma Ltd.?
The quarterly shareholding pattern of Onesource Specialty Pharma Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Onesource Specialty Pharma Ltd. on Sharpely?
Share price data for Onesource Specialty Pharma Ltd. is updated as of 9 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.